Metlife Inc

Metlife Inc

MET - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$64.45B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Metlife IncMetlife Inc12.72.39%23%0.81

Earnings Call Q3 2026

November 5, 2026 - AI Summary

Record profitability + strong broad-based growth (good/surprising) - Q3 adjusted earnings: $1.8B / $2.78 EPS, +17% (ex-notable items), and $2.85 adjusted EPS, +22% YoY. - Highest adjusted EPS quarter ever; CEO emphasized growth breadth: no single business drove results. - Variable investment income (VII): $720M pretax (private equity/VC returns >4%, vs 3% a year ago) was a major contributor but “did not define” the quarter.
Expense discipline despite acquisition + AI productivity tailwind (good) - Direct expense ratio: 11.9% (vs 11.6% prior year; on track to beat 12.1% full-year target). - Management expects AI/technology-driven productivity to offset higher costs from PineBridge absorption (noted as structurally higher expense). - Note: Stock comp/incentive-related items were discussed as a modest headwind (investor question: ~1–2 points impact on expense ratio).
Segment performance highlights + underwriting trends (good, with some watch items) - Group Benefits: adjusted earnings $523M, +14% YoY; group life mortality ratio 79.5% (below target range 83–88%). Non-medical health ratio 72.3% (within 70–75%). - RIS (Retirement & Income Solutions): adjusted earnings $478M, +12%; total investment spread 130 bps (above guidance 100–120 bps) supported by VII. - Asia: adjusted earnings $550M, +21% constant currency, driven by VII + favorable markets; sales down -6% constant currency in Q3 but +10% YTD. - Latin America: adjusted earnings $229M; impacted by weaker encaje (negative -3% vs positive +6% prior year), but top-line momentum remains strong (PFOs +14% constant currency, sales +6%).

Exclusive for Stockcircle Pro members

Sign upSign Up
$108.20

Target Price by Analysts

5.4% upsideMetlife Target Price DetailsTarget Price
$213.87

Current Fair Value

108.4% upside

Undervalued by 108.4% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$64.45 Billion
Enterprise Value$66.34 Billion
Annual dividend$2.35
Dividend yield2.39%
Earnings per Share$4.8
Beta0.77
Outstanding Shares635,000,000

Return

Return on Equity22.76%ROE
Return on Assets0.68%
Return on Invested Capital1.29%

Valuation & Multiples

P/E Ratio12.73P/E Ratio
PEG7.6PEG
Price to Sales0.79Price to Sales
Price to Book Ratio2.93Price to Book Ratio
Enterprise Value to Revenue0.8
Enterprise Value to EBIT9.28
Enterprise Value to Net Income13
Total Debt to Enterprise0.33
Debt to Equity0.98Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 4, 2026
EPS
$2.78
Est. $2.77
Revenue
$20.52 B
Est. $19.86 B

Next Earnings Call

Expected Date
February 3, 2027
EPS Estimate
$2.62
Consensus analyst estimate
Revenue Estimate
$20.68 B
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 1.18, the ratio is above 1, so institutions hold more puts than calls. That is a more cautious stance.

Put/Call Ratio1.1802▲ 7.52%
Total Calls238,346▼ 92.60%
Total Puts281,300▼ 92.10%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %12.78%▼ 62.24%
Total Invested$7.83B▼ 81.07%
Investors Holding843▼ 674.00%

About Metlife Inc

46,500 employees
CEO: Michel Khalaf

MetLife, Inc., through its subsidiaries and affiliates ('MetLife'), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help its individual and institution...

Metlife Insider Information FAQ

Stockcircle tracks 9 top investors with a current 13F position in Metlife. Notable holders include Bridgewater Associates. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 1 top investor increased or opened positions and 5 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle lists 1 politician trade disclosure tied to Metlife in the last twelve months, drawn from periodic financial disclosure reports. 1 politician traded Metlife in the past year.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.